More Provident Funds And Pension (XTAE:MPP) Research & Development: ₪0.0 Mil (TTM As of Mar. 2026)


XTAE:MPP More Provident Funds And Pension Ltd XTAE:MPP
84 GF Score
Price ₪16.10
GF Value ₪10.67
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is More Provident Funds And Pension Research & Development?

More Provident Funds And Pension XTAE:MPP 84 Research & Development is ₪0.0 Mil as of Mar. 2026. GuruFocus rates XTAE:MPP with a GF Score™ of 84/100 and a GF Value™ of ₪10.67 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. More Provident Funds And Pension's Research & Development for the three months ended in Mar. 2026 was ₪0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₪0.0 Mil.

More Provident Funds And Pension  (XTAE:MPP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

More Provident Funds And Pension Research & Development Related Terms

More Provident Funds And Pension Research & Development Historical Data

* Premium members only.

The historical data trend for More Provident Funds And Pension's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

More Provident Funds And Pension Research & Development Chart

More Provident Funds And Pension Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

More Provident Funds And Pension Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XTAE:MPP
84GF Score
More Provident Funds And Pension Ltd XTAE:MPP
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

More Provident Funds And Pension Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₪0.0 Mil mean?
More Provident Funds And Pension (XTAE:MPP) has a Research & Development of ₪0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on More Provident Funds And Pension and its competitors.
Is More Provident Funds And Pension's Research & Development too high?
More Provident Funds And Pension's current Research & Development is ₪0.0 Mil. Overall, More Provident Funds And Pension has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does More Provident Funds And Pension's Research & Development compare to BLK and BX?
More Provident Funds And Pension's Research & Development of ₪0.0 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on More Provident Funds And Pension and its competitors. More Provident Funds And Pension's current Research & Development is ₪0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is More Provident Funds And Pension stock overvalued right now?
Based on GuruFocus' analysis, More Provident Funds And Pension (XTAE:MPP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₪10.67, compared to a current price of ₪16.10 — trading 50.9% above its estimated fair value. The current Research & Development is ₪0.0 Mil. More Provident Funds And Pension's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For More Provident Funds And Pension (XTAE:MPP), the current Research & Development is ₪0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is More Provident Funds And Pension (XTAE:MPP) Overvalued in 2026?

Based on GuruFocus' analysis, More Provident Funds And Pension stock appears to be overvalued. The current stock price of ₪16.10 is trading 50.9% above its estimated GF Value™ of ₪10.67. GuruFocus considers More Provident Funds And Pension to be Significantly Overvalued.

Key valuation signals for XTAE:MPP:

  • Research & Development: ₪0.0 Mil
  • GF Value™: ₪10.67 vs. price of ₪16.10 (50.9% above fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the XTAE:MPP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

More Provident Funds And Pension Business Description

Address Ben Gurion Road 2, PO Box: 514956465, Ramat Gan, ISR, 5257334
More Provident Funds And Pension Ltd, formerly More Provident Funds Ltd offers variety of long-term savings routes at different risk levels. The company offers provident funds, study funds and investment provident funds.
84GF Score

Get the complete analysis for XTAE:MPP

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪16.10
Price
₪10.67
GF Value